Assessing the Clinical Features and Blood Biochemistries of Acute Organophosphorus Chemical Warfare Agents in Iranian Veterans
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 11 No. 2 (2021),
15 Khordad 2021
,
Page 32857
https://doi.org/10.32598/ijmtfm.v11i2.32857
Abstract
Background: Nerve Agents (NAs) are a chemical weapons, and their use is prohibited. They were used for numerous-times in the warfare of Iraq against Iran. The present study aimed to assess the clinical features and laboratory findings of the acute poisoning manifestations of organophosphorus chemical warfare agents (NAs) in Iranian veterans early after exposure.
Methods: A total of 25 male NAs-exposed cases were enrolled in the present study. We used the medical records of early combat in 1990 for data collection. The data of the exposed-victims were unavailable for a long time. Clinical features were evaluated and fasting blood glucose, sodium, potassium, insulin level, and protein electrophoresis were measured on the first day of exposure.
Results: Potassium, sodium, fasting blood glucose, and protein electrophoresis were abnormally noticeable on the first day post-exposure. The clinical features of the studied cases were manifested in the muscarinic and nicotinic systems, and Central Nervous Systems (CNS). Miosis, cramp, restlessness, and respiratory symptoms were dominant features in the study subjects.
Conclusion: The investigated exposed-victims of NAs indicated hypokalemia, hyperkalemia, hypoglycemia, normal insulin levels, and abnormal protein electrophoresis. The clinical features of the cholinergic crisis were markedly significant in three levels of the muscarinic, nicotinic, and CNS manifestations. Our findings suggested that the exposed cases were against a significant dose of NAs.
- Nerve agents
- Chemical warfare agents
- Organophosphorus
- Soman
- Sarin
- Warfare
How to Cite
References
Szinicz L. History of chemical and biological warfare agents. Toxicology. 2005; 214(3):167-81. [DOI:10.1016/j.tox.2005.06.011]
Okudera H, Morita H, Iwashita T, Shibata T, Otagiri T, Kobayashi S, et al. Unexpected nerve gas exposure in the city of Matsumoto: Report of rescue activity in the first sarin gas terrorism. Am J Emerg Med. 1997; 15(5):527-8. [DOI:10.1016/S0735-6757(97)90201-1]
Asai Y, Arnold JL. Terrorism in Japan. Prehosp Disaster Med. 2003; 18(2):106-14. [DOI:10.1017/S1049023X00000844] [PMID]
Haines DD, Fox SC. Acute and long-term impact of chemical weapons: Lessons from the Iran-Iraq war. Forensic Sci Rev. 2014; 26(2):97-114. [PMID]
Wikipedia Encyclopedia. Iran–Iraq war [Internet]. 2021 [Updated 2021 May 07]. Available from: https://en.wikipedia.org/wiki/Iran%E2%80%93Iraq_War
Wikipedia Encyclopedia. Chemical warfare [Internet]. 2021 [Updated: 4 May 2021; cited 11 May 2021]. Available from: https://en.wikipedia.org/wiki/Chemical_warfare
Pitschmann V. Overall view of chemical and biochemical weapons. Toxins (Basel). 2014; 6(6):1761-84. [DOI:10.3390/toxins6061761] [PMID] [PMCID]
Nepovimova E, Kuca K. Chemical warfare agent NOVICHOK - mini-review of available data. Food Chem Toxicol. 2018; 121:343-50. [DOI:10.1016/j.fct.2018.09.015] [PMID]
Schwenk M. Chemical warfare agents. Classes and targets. Toxicol Lett. 2018; 293:253-63. [DOI:10.1016/j.toxlet.2017.11.040]
Balali-Mood M, Balali-Mood K. Neurotoxic disorders of organophosphorus compounds and their managements. Arch Iran Med. 2008; 11(1):65-89. https://www.sid.ir/en/Journal/ViewPaper.aspx?ID=100011
Bigley AN, Raushel FM. The evolution of phosphotriesterase for decontamination and detoxification of organophosphorus chemical warfare agents. Chem Biol Interact. 2019; 308:80-8. [DOI:10.1016/j.cbi.2019.05.023] [PMID] [PMCID]
Gao X, Lin H, Ray R, Ray P. Toxicogenomic studies of human neural cells following exposure to organophosphorus chemical warfare nerve agent VX. Neurochem Res. 2013; 38(5):916-34. [DOI:10.1007/s11064-013-0996-1] [PMID]
Nakamura K. [Chemical weapons and chemical terrorism (Japanese)]. Nihon Hoigaku Zasshi. 2005; 59(2):126-35. [PMID]
Busl KM, Bleck TP. Treatment of neuroterrorism. Neurotherapeutics. 2012; 9(1):139-57. [DOI:10.1007/s13311-011-0097-2] [PMID] [PMCID]
Lallement G, Clarençon D, Galonnier M, Baubichon D, Burckhart MF, Peoc’h M. Acute soman poisoning in primates neither pretreated nor receiving immediate therapy: Value of Gacyclidine (GK-11) in delayed medical support. Arch Toxicol. 1999; 73(2):115-22. [DOI:10.1007/s002040050595] [PMID]
Moshiri M, Darchini-Maragheh E, Balali-Mood M. Advances in toxicology and medical treatment of chemical warfare nerve agents. Daru. 2012; 20(1):81. [DOI:10.1186/2008-2231-20-81] [PMID] [PMCID]
Martin T, Lobert S. Chemical warfare. Toxicity of nerve agents. Crit Care Nurse. 2003; 23(5):15-20; quiz 21-2. [DOI:10.4037/ccn2003.23.5.15] [PMID]
Niven AS, Roop SA. Inhalational exposure to nerve agents. Respir Care Clin N Am. 2004; 10(1):59-74. [DOI:10.1016/S1078-5337(03)00049-2] [PMID]
Abu-Qare AW, Abou-Donia MB. Sarin: Health effects, metabolism, and methods of analysis. Food Chem Toxicol. 2002; 40(10):1327-33. [DOI:10.1016/S0278-6915(02)00079-0] [PMID]
Fletcher HP, Noble SA, Spratto GR. Effects of the acetylcholinesterase inhibitor pinacolyl methylphosphonofluoridate (soman) on selected endocrine, glucose, and catecholamine levels in fasted and fed rats. Toxicology. 1988; 52(3):323-9. [DOI:10.1016/0300-483X(88)90136-9] [PMID]
Fletcher HP, Akbar WJ, Peoples RW, Spratto GR. Effect of acute soman on selected endocrine parameters and blood glucose in rats. Fundam Appl Toxicol. 1988; 11(4):580-6. [DOI:10.1016/0272-0590(88)90122-4] [PMID]
Kant GJ, Shih TM, Bernton EW, Fein HG, Smallridge RC, Mougey EH. Effects of soman on neuroendocrine and immune function. Neurotoxicol Teratol. 1991; 13(2):223-8. [DOI:10.1016/0892-0362(91)90014-N] [PMID]
Suzuki J, Kohno T, Tsukagosi M, Furuhata T, Yamazaki K. Eighteen cases exposed to sarin in Matsumoto, Japan. Intern Med. 1997; 36(7):466-70. [DOI:10.2169/internalmedicine.36.466] [PMID]
Abou-Donia MB, Siracuse B, Gupta N, Sobel Sokol A. Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: Critical review. Crit Rev Toxicol. 2016; 46(10):845-75. [DOI:10.1080/10408444.2016.1220916] [PMID] [PMCID]
Yanagisawa N, Morita H, Nakajima T, Shimizu M, Hirabayashi H, Okudera H, et al. Sarin poisoning in Matsumoto, Japan. Lancet. 1995; 346(8970):290-3. [DOI:10.1016/S0140-6736(95)92170-2] [PMID]
Nozaki H, Hori S, Shinozawa Y, Fujishima S, Takuma K, Kimura H, et al. Relationship between pupil size and acetylcholinesterase activity in patients exposed to sarin vapor. Intensive Care Med. 1997; 23(9):1005-7. [DOI:10.1007/s001340050447] [PMID]
Yanagisawa N, Morita H, Nakajima T. Sarin experiences in Japan: Acute toxicity and long-term effects. J Neurol Sci. 2006; 249(1):76-85. [DOI:10.1016/j.jns.2006.06.007] [PMID]
Adeyinka A, Kondamudi NP. Cholinergic Crisis [monograph online]. Treasure Island (FL): StatPearls Publishing; 2021. https://www.ncbi.nlm.nih.gov/books/NBK482433/
Yokoyama K. Our recent experiences with sarin poisoning cases in Japan and pesticide users with references to some selected chemicals. Neurotoxicology. 2007; 28(2):364-73. [DOI:10.1016/j.neuro.2006.04.006] [PMID]
Proctor SP, Heaton KJ, Heeren T, White RF. Effects of sarin and cyclosarin exposure during the 1991 Gulf War on neurobehavioral functioning in US army veterans. Neurotoxicology. 2006; 27(6):931-9. [DOI:10.1016/j.neuro.2006.08.001] [PMID]
Hulse EJ, Haslam JD, Emmett SR, Woolley T. Organophosphorus nerve agent poisoning: Managing the poisoned patient. Br J Anaesth. 2019; 123(4):457-463. [DOI:10.1016/j.bja.2019.04.061] [PMID]
- Abstract Viewed: 173 times
- pdf Downloaded: 200 times